Home > Analytics > SOLARA ACTIVE PHARMA SCIENCE

SOLARA ACTIVE PHARMA SCIENCE
Intrinsic Value | Fundamental Analysis

BOM : 541540     NSE : SOLARA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : Average [>25% and <50%]
Sep 27,2022
Price(EOD): ₹ 431.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,554.30 Cr
Value of ₹ 1 Lac invested in SOLARA ACTIVE PHARMA SCIENCE
on Jun 27,2018 (price: ₹ 273.60)

₹ 1 L

₹ 1.58 L

1W : -4.9% 1M : -2.6% 1Y : -74.2%
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCE
Please provide your vote to see the results
SOLARA ACTIVE PHARMA SCIENCE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
SOLARA ACTIVE PHARMA SCIENCE -4.9% -2.6% -74.2%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 2% 16.6%
DIVIS LABORATORIES 2.9% 2.5% -29.2%
DR REDDYS LABORATORIES 0.8% -1% -14.9%
CIPLA 3% 7.9% 10.1%
GLAND PHARMA -5% -13.5% -47.2%
PIRAMAL ENTERPRISES -8.3% -55.7% -68%
CADILA HEALTHCARE -1.6% -5.7% -37.2%
TORRENT PHARMACEUTICALS 2.2% -0.9% -2.4%

FUNDAMENTAL ANALYSIS OF SOLARA ACTIVE PHARMA SCIENCE

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 SOLARA is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF SOLARA ACTIVE PHARMA SCIENCE

 
Valuation Score
[As on : Sep 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
-12.45
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -124.85 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

1.02
P/B Calculated based on Book Value of Rs 1,523.87 Cr
[Latest Year - Mar2022 - Consolidated Results ]

1.3
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,192.84 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF SOLARA ACTIVE PHARMA SCIENCE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-23%
31%
45%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF SOLARA ACTIVE PHARMA SCIENCE



SOLARA ACTIVE PHARMA SCIENCE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF SOLARA ACTIVE PHARMA SCIENCE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.67
0.38
0.71
0.59
0.67
0.38
0.72
0.59
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF SOLARA ACTIVE PHARMA SCIENCE

Pledged Promoter Shares
27.98 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF SOLARA ACTIVE PHARMA SCIENCE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-8.52%
-7.24%
-0.32%
-1008.84%
-18.62%
-86.27%
-162.06%
-132.83%
QtrlyTrend
-8
Latest Qtr: Jun2022
Quarterly Result Analysis →


SOLARA ACTIVE PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -2.3% 0% -13.7%
S&P BSE ALLCAP -4.8% -2.4% -1.2%
S&P BSE SMALL CAP -4.9% -1.2% 0.5%
S&P BSE MIDSMALLCAP -5.1% -1.5% -0.9%
NSE Indices1W1M1Y
NIFTY 500 -4.8% -2.5% -1.8%
NIFTY SMALLCAP250 -4.8% -1.2% -2%
NIFTY500 MULTICAP 50:25:25 -4.9% -2.1% -1.1%
NIFTY MID SMALL400 -5.2% -1.7% 0.9%

You may also like the below Video Courses


FAQ about SOLARA ACTIVE PHARMA SCIENCE


Is SOLARA ACTIVE PHARMA SCIENCE good for long term investment?

As on Sep 27,2022, the Fundamentals of SOLARA ACTIVE PHARMA SCIENCE look Strong and hence it may be good for long term investment! See Financial Performance of SOLARA ACTIVE PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SOLARA ACTIVE PHARMA SCIENCE UnderValued or OverValued?

As on Sep 27,2022, SOLARA ACTIVE PHARMA SCIENCE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SOLARA ACTIVE PHARMA SCIENCE ?

As on Sep 27,2022, the Intrinsic Value of SOLARA ACTIVE PHARMA SCIENCE is Rs. 330.04 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 557.81
Fair Value [Median EV / Sales Model] : Rs. 330.04
Fair Value [Median Price / Sales Model] : Rs. 298.21
Estimated Median Fair Value of SOLARA ACTIVE PHARMA SCIENCE : Rs. 330.04

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is SOLARA ACTIVE PHARMA SCIENCE trading at a Premium or Discount?

As on Sep 27,2022, SOLARA ACTIVE PHARMA SCIENCE is trading at a Premium of 31% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].